Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ISTALOL | Bausch Health Companies | N-021516 RX | 2004-06-04 | 1 products, RLD, RS |
TIMOPTIC | Bausch Health Companies | N-018086 RX | 1982-01-01 | 2 products, RLD |
TIMOPTIC IN OCUDOSE | Bausch Health Companies | N-019463 RX | 1986-11-05 | 2 products, RLD, RS |
TIMOPTIC-XE | Bausch Health Companies | N-020330 RX | 1993-11-04 | 2 products, RLD |
TIMOLOL MALEATE | Sandoz | N-020963 RX | 1998-10-21 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TIMOLIDE 10-25 | Merck & Co | N-018061 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BETIMOL | Thea Pharma | N-020439 RX | 1995-03-31 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
COSOPT | Thea Pharma | N-020869 RX | 1998-04-07 | 1 products, RLD, RS |
COSOPT PF | Thea Pharma | N-202667 RX | 2012-02-01 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
betimol | New Drug Application | 2024-04-17 |
brimonidine tartrate and timolol maleate | ANDA | 2025-02-19 |
brimonidine tartrate/timolol maleate | ANDA | 2024-05-16 |
brimonidine tartrate/timolol maleate ophthalmic solution | ANDA | 2025-03-10 |
combigan | New Drug Application | 2024-07-26 |
cosopt | New Drug Application | 2024-04-17 |
cosopt pf | New Drug Application | 2024-01-08 |
dorzolamide and timolol | ANDA | 2024-05-25 |
dorzolamide hcl /timolol maleate | ANDA | 2013-01-29 |
dorzolamide hcl and timolol maleate | ANDA | 2018-02-13 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ocular hypertension | D009798 | EFO_1001069 | H40.0 | 1 | 1 | 14 | 10 | 6 | 32 |
Hypertension | D006973 | EFO_0000537 | I10 | 1 | 1 | 14 | 9 | 4 | 29 |
Glaucoma | D005901 | EFO_0000516 | H40 | 1 | — | 10 | 14 | 4 | 29 |
Open-angle glaucoma | D005902 | EFO_0004190 | H40.1 | 1 | — | 4 | 6 | 5 | 16 |
Low tension glaucoma | D057066 | EFO_1001022 | H40.12 | — | — | — | 1 | — | 1 |
Angle-closure glaucoma | D015812 | — | — | — | — | — | 1 | — | 1 |
Drug common name | Timolol |
INN | timolol |
Description | (S)-timolol (anhydrous) is the (S)-(-) (more active) enantiomer of timolol. A beta-adrenergic antagonist, both the hemihydrate and the maleate salt are used in the mangement of glaucoma, hypertension, angina pectoris and myocardial infarction, and for the prevention of migraine. It has a role as an antiglaucoma drug, an antihypertensive agent, an anti-arrhythmia drug and a beta-adrenergic antagonist. It is a conjugate base of a (S)-timolol(1+). It is an enantiomer of a (R)-timolol. |
Classification | Small molecule |
Drug class | beta-blockers (propranolol type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1 |
PDB | — |
CAS-ID | 26839-75-8 |
RxCUI | — |
ChEMBL ID | CHEMBL499 |
ChEBI ID | 9599 |
PubChem CID | 33624 |
DrugBank | DB00373 |
UNII ID | 5JKY92S7BR (ChemIDplus, GSRS) |